Jessica Nance, MD, MS, discusses the significance of surrogate end points, like functional assessments, in clinical trials of treatments for Duchenne muscular dystrophy and their implications for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback